KTRA NASDAQ
Kintara Therapeutics, Inc.
1W: -96.5%
1M: -96.5%
3M: -97.6%
1Y: -99.3%
3Y: -100.0%
5Y: -99.9%
$0.22
Last traded 2024-10-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-33M
Net Income
-153.4% YoY
$-3,727M
Free Cash Flow
-35764.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-202.1%
ROA-150.6%
ROIC0.0%
Valuation
P/E-0.3
P/B0.6
EV/EBITDA-1.1
Leverage
Debt/Equity0.02
Current Ratio1.15
Interest Cov.-34.7x
Quality Scores
Piotroski F0/9
Altman Z-7.55
Beneish M0.00